SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Texas Biotech (TXB) -- Ignore unavailable to you. Want to Upgrade?

To: ccryder who wrote (773)2/29/2000 9:19:00 PM
From: debra vogt  Read Replies (1) | Respond to of 834
 
I bought this stock in the winter of 1997, so IMO it's about time:) Guess it depends on how you look at it! Regards, Debra



To: ccryder who wrote (773)3/1/2000 12:26:00 AM
From: satish kamat  Read Replies (1) | Respond to of 834
 
not sure if you referring to the handling of NOVASTAN.
i am rather surprised how undervalued this is, given their pipeline. erica wang of PB calls it the biotech Gem. interestingly she has the habit of putting a 12 month target which is 25% away, when the stock moves 25% above her target, she moves up the target another 50% a month later.
satish kamat


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News